Stroke Recovery
Post-stroke recovery research targets neuroplasticity-driven functional restoration after ischemic brain injury. Russian clinical literature describes Semax in small-cohort stroke recovery trials. No FDA or EMA Phase 3 trials for Semax in stroke recovery as of 2026.
